SUPERNUS PHARMACEUTICALS, INC. Derivative Liability, Noncurrent
SUPERNUS PHARMACEUTICALS, INC. (SUPN) had Derivative Liability, Noncurrent of $23.00 thousand as of 2017-03-31, per its 10-Q filed 2017-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2018-03-01
- 2017-03-31: Derivative Liability, Noncurrent $23.00K.
- 2016-12-31: Derivative Liability, Noncurrent $114.00K.
- 2016-09-30: Derivative Liability, Noncurrent $287.00K.
- 2016-06-30: Derivative Liability, Noncurrent $412.00K.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2017-03-31 | $23.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $114.00K 10-K · filed 2018-03-01 |
| 2016-09-30 | $287.00K 10-Q · filed 2017-01-20 |
| 2016-06-30 | $412.00K 10-Q/A · filed 2017-01-23 |
| 2016-03-31 | $535.00K 10-Q/A · filed 2017-01-20 |
| 2015-12-31 | $854.00K 10-K · filed 2017-03-16 |
| 2015-09-30 | $1.16M 10-Q/A · filed 2017-01-20 |
| 2015-06-30 | $2.07M 10-Q/A · filed 2017-01-23 |
| 2015-03-31 | $2.69M 10-Q/A · filed 2017-01-20 |
| 2014-12-31 | $6.56M 10-Q/A · filed 2017-01-20 |
| 2014-09-30 | $7.26M 10-Q/A · filed 2017-01-20 |
| 2014-06-30 | $8.83M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $9.56M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $12.64M 10-K · filed 2015-03-12 |
| 2013-09-30 | $22.21M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $18.06M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $172.00K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $251.00K 10-K · filed 2014-03-21 |
| 2012-09-30 | $1.46M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $1.17M 10-Q · filed 2012-08-13 |
| 2012-03-31 | $1.02M 10-Q · filed 2012-06-08 |
| 2011-12-31 | $697.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |